Cargando…

Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells

BACKGROUND: Suboptimal activation of T lymphocytes by melanoma cells is often due to the defective expression of class I major histocompatibility antigens (MHC-I) and costimulatory molecules. We have previously shown that geranylgeranyl transferase inhibition (done with GGTI-298) stimulates anti-mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarrabayrouse, Guillaume, Pich, Christine, Moriez, Raphaël, Armand-Labit, Virginie, Rochaix, Philippe, Favre, Gilles, Tilkin-Mariamé, Anne-Françoise
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815789/ https://www.ncbi.nlm.nih.gov/pubmed/20140259 http://dx.doi.org/10.1371/journal.pone.0009043

Ejemplares similares

Melanoma-expressed CD70 is involved in invasion and metastasis
por: Pich, Christine, et al.
Publicado: (2016)

Statins Reduce Melanoma Development and Metastasis through MICA Overexpression
por: Pich, Christine, et al.
Publicado: (2013)

In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
por: Teiti, Iotefa, et al.
Publicado: (2015)

Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity
por: Pich, Christine, et al.
Publicado: (2016)

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012)

Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth
por: Gallardo, Franck, et al.
Publicado: (2018)

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
por: Lane, Ryan S., et al.
Publicado: (2018)

IFNγ score–based neoadjuvant immunotherapy for stage III melanoma
por: Fukuda, Keitaro
Publicado: (2023)

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
por: Adair, Jennifer E., et al.
Publicado: (2021)

TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
por: Mauldin, Ileana S, et al.
Publicado: (2013)

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
por: Reijers, Irene L.M., et al.
Publicado: (2023)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
por: Sucker, Antje, et al.
Publicado: (2017)

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
por: Shen, Hongxing, et al.
Publicado: (2022)

IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
por: Homann, Lorenzo, et al.
Publicado: (2022)

Development of IFN-γ resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
por: Fojtova, M, et al.
Publicado: (2007)

Deciphering Repertoire of B16 Melanoma Reactive TCRs by Immunization, In Vitro Restimulation and Sequencing of IFNγ-Secreting T Cells
por: Izosimova, Anna V., et al.
Publicado: (2021)

Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
por: Cestac, Philippe, et al.
Publicado: (2005)

USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
por: Hong, Bangxing, et al.
Publicado: (2014)

DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment
por: Lv, Qiang, et al.
Publicado: (2017)

Effect of iron sources on the glycosylation macroheterogeneity of human recombinant IFN-γ produced by CHO cells during batch processes
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

IFNγ producing CD8(+) T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas
por: Buferne, Michel, et al.
Publicado: (2015)

9-Gene Signature Correlated With CD8(+) T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
por: Yan, Kexin, et al.
Publicado: (2021)

A pilot study on acute inflammation and cancer: a new balance between IFN-γ and TGF-β in melanoma
por: Ma, Yue-mei, et al.
Publicado: (2009)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
por: Woods, Katherine, et al.
Publicado: (2016)

A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
por: van Duijn, Anneloes, et al.
Publicado: (2021)

Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma
por: McKinney, Andrea J., et al.
Publicado: (2011)

Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation
por: Jørgensen, Nanna, et al.
Publicado: (2020)

Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.
por: Hershey, P., et al.
Publicado: (1978)

Combining ADA, Protein and IFN- γ Best Allows Discrimination Between Tuberculous and Malignant Pleural Effusion
por: Kim, Young-Chul, et al.
Publicado: (1997)

IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts
por: Rottman, Martin, et al.
Publicado: (2008)

IFN-γ modulates Ly-49 receptors on NK cells in IFN-γ-induced pregnancy failure
por: Li, Zhong-Yin, et al.
Publicado: (2015)

Dynamical modelling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Colon-specific immune microenvironment regulates cancer progression versus rejection
por: Trimaglio, Giulia, et al.
Publicado: (2020)

Characterization of metalloprotease and serine protease activities in batch CHO cell cultures: control of human recombinant IFN-γ proteolysis by addition of iron citrate
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
por: Paraiso, K H T, et al.
Publicado: (2010)

Radiosensitivity of human ovarian carcinoma and melanoma cells to γ-rays and protons
por: Keta, Otilija, et al.
Publicado: (2014)

β- and γ-Actins in the nucleus of human melanoma A375 cells
por: Migocka-Patrzałek, Marta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ela0o9pgbf7r8ot7t557jtqvtj